Heart failure (HF) is a significant cause of morbidity and mortality worldwide. Circulating
biomarkers reflecting pathophysiological pathways involved in HF development and …

The heart failure epidemic is growing and its prevention, in order to reduce associated
hospital readmission rates and its clinical and economic burden, is a key issue in modern …

Chronic heart failure (CHF) is the final outcome of many cardiovascular diseases, and is a
severe health issue faced by the elderly population. Mixed lineage kinase 3 (MLK3), a …

The significant morbidity and mortality associated with heart failure with reduced ejection
fraction (HFrEF) or heart failure with preserved ejection fraction (HFpEF) justify the search for …

Attention-deficit/hyperactivity disorder (ADHD) is a prevalent and serious
neurodevelopmental disorder characterized by symptoms of inattention and/or hyperactivity …

Mitochondria ensure the supply of cellular energy through the production of ATP via
oxidative phosphorylation. The alteration of this process, called mitochondrial dysfunction …

Obesity is defined as excessive body fat accumulation, and worldwide obesity has nearly
tripled since 1975. Excess of free fatty acids (FFAs) and triglycerides in obese individuals …

Chemotherapy with anthracycline-based regimens remains a cornerstone of treatment of
many solid and blood tumors but is associated with a significant risk of cardiotoxicity, which …

Mitochondria provide energy to the cell during aerobic respiration by supplying~ 95% of the
adenosine triphosphate (ATP) molecules via oxidative phosphorylation. These organelles …

Heart failure (HF) is a clinical syndrome characterized by typical symptoms that usually
occur at the end stage of various heart diseases and lead to death. Daidzein (DAI), an …